Keyphrases
Metaiodobenzylguanidine Scintigraphy
64%
I-123 IMP
32%
Mild Cognitive Impairment Due to Alzheimer's Disease
32%
Education Group
32%
Computed Tomography-based Attenuation Correction
32%
Cognitive Reserve
32%
Differential Diagnosis
32%
Sampled-data Systems
32%
Normal Database
32%
Cerumen Impaction
32%
SPECT Myocardial Perfusion Imaging
32%
Scatter Correction
32%
Multicenter Database
32%
Dementia with Lewy Bodies
32%
Temporal Bone Anatomy
32%
Morphometry
32%
123I-FP-CIT SPECT
32%
IPad
32%
Acute Ischemic
32%
Dopamine Transporter Binding
32%
Gender Effect
32%
Section Plane
32%
Long-term Investigation
32%
Brain Perfusion Single-photon Emission Computed Tomography
32%
Dementia Diagnosis
32%
FDG Positron Emission Tomography
32%
Ratio Distribution
32%
Air Content
25%
Attenuation Correction
24%
Voxel-based Morphometry
21%
Brain Magnetic Resonance Imaging
21%
Three-dimensional Stereotactic Surface Projections
21%
Age Groups
16%
Binding Ratio
16%
X-ray Computed Tomography (X-CT)
16%
Striatal
16%
Chang Method
16%
Digital Biomarkers
16%
Count Rate
13%
Automated Blood Sampling
12%
177Lu-DOTATATE
12%
131I-MIBG
12%
Temporal Area
12%
Conversion to Alzheimer Disease
12%
Volume-based Morphometry
12%
123I-IMP
10%
Whole Brain
10%
Heart-to-mediastinum Ratio
10%
Projection Analysis
10%
Gray Matter Atrophy
10%
Neuroscience
Positron Emission Tomography
100%
Alzheimer's Disease
96%
Iodine-123
96%
Magnetic Resonance Imaging
73%
Mild Cognitive Impairment
68%
Single-Photon Emission Computed Tomography
46%
Fluorine-18
42%
Dopamine Transporter
35%
Positron Emission Tomography
32%
Iobenguane
32%
Inosinic Acid
32%
Neural Network
32%
Computed Tomography
32%
Serotonin Transporter
32%
Multiple System Atrophy
32%
Metabolic Pathway
22%
Skull
13%
Striatum
12%
Cerebral Infarction
10%
Cerebrovascular Disease
10%
Statistical Parametric Mapping
10%
Brainstem
8%
Association Cortex
7%
Hippocampus
6%
Cognitive Function
6%
Behavior (Neuroscience)
6%
Diffuse Lewy Body Disease
6%
Neuropsychological Test
6%
Structural Magnetic Resonance Imaging
6%
Positron Emission Tomography-Computed Tomography
6%
Neurodegeneration
6%
Cognitive Tests
6%
Isoflurane
6%
Radiopharmaceutical
6%
Occipital Lobe
5%
Medicine and Dentistry
Cancer Staging
32%
Whole Body MRI
32%
Nuclear Medicine
32%
Positron Emission Tomography - Magnetic Resonance Imaging
32%
Cerumen Impaction
32%
Trachea
32%
Alzheimer's Disease
32%
Iodine 123
32%
(3 Iodobenzyl)guanidine
32%
Computer Assisted Tomography
32%
Positron Emission Tomography-Computed Tomography
32%
Postmortem Change
32%
Small Cell Lung Cancer
32%
Biological Marker
24%
Positron Emission Tomography
24%
Time of Death
19%
Early Diagnosis
16%
Magnetic Resonance Imaging
13%
Voxel-Based Morphometry
12%
Diagnosis of Alzheimer's Disease
11%
Inosine Phosphate
9%
Differential Diagnosis
8%
Amyloid
8%
Early Intervention
8%
Diagnostic Imaging
8%
Mild Cognitive Impairment
8%
(3 Iodobenzyl)guanidine I 131
8%
Lutetium 177
8%
Single-Photon Emission Computed Tomography
8%
Brain Blood Flow
8%
Therapy Effect
8%
Tau
8%
Patient Selection
8%
Diffuse Lewy Body Disease
6%
Intravenous Drug Administration
6%
Occipital Lobe
6%
Gray Matter
6%
Neuropsychological Test
6%
Diagnosis
6%
Isoflurane
6%
Anesthetic Agent
6%
Forensic Medicine
6%
Inhalation Anesthesia
6%
Single Photon Emission Computed Tomography-Computed Tomography
5%
Lung Cancer
5%
